Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 21:9:e10801.
doi: 10.7717/peerj.10801. eCollection 2021.

Evaluation of two fluorescence immunoassays for the rapid detection of SARS-CoV-2 antigen-new tool to detect infective COVID-19 patients

Lorena Porte  1 , Paulette Legarraga  1 , Mirentxu Iruretagoyena  1 , Valeska Vollrath  1 , Gabriel Pizarro  1 , Jose Munita  2   3   4 , Rafael Araos  2   3   4 , Thomas Weitzel  1   3
Affiliations

Evaluation of two fluorescence immunoassays for the rapid detection of SARS-CoV-2 antigen-new tool to detect infective COVID-19 patients

Lorena Porte et al. PeerJ. .

Abstract

Background: Real-Time Reverse-Transcription Polymerase Chain Reaction (RT-PCR) is currently the only recommended diagnostic method for SARS-CoV-2. However, rapid immunoassays for SARS-CoV-2 antigen could significantly reduce the COVID-19 burden currently weighing on laboratories around the world.

Methods: We evaluated the performance of two rapid fluorescence immunoassays (FIAs), SOFIA SARS Antigen FIA (Quidel Corporation, San Diego, CA, USA) and STANDARD F COVID-19 Ag FIA (SD Biosensor Inc., Gyeonggi-do, Republic of Korea), which use an automated reader. The study used 64 RT-PCR characterized clinical samples (32 positive; 32 negative), which consisted of nasopharyngeal swabs in universal transport medium.

Results: Of the 32 positive specimens, all from patients within 5 days of symptom onset, the Quidel and SD Biosensor assays detected 30 (93.8%) and 29 (90.6%) samples, respectively. Among the 27 samples with high viral loads (Ct ≤ 25), the two tests had a sensitivity of 100%. Specificity was 96.9% for both kits.

Conclusion: The high performance of the evaluated FIAs indicates a potential use as rapid and PCR-independent tools for COVID-19 diagnosis in early stages of infection. The excellent sensitivity to detect cases with viral loads above ~106 copies/mL (Ct values ≤ 25), the estimated threshold of contagiousness, suggests that the assays might serve to rapidly identify infective individuals.

Keywords: Antigen detection; Covid-19; Diagnosis; Rapid diagnostic test; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Bullard J, Dust K, Funk D, Strong JE, Alexander D, Garnett L, Boodman C, Bello A, Hedley A, Schiffman Z, Doan K, Bastien N, Li Y, Van Caeseele PG, Poliquin G. Predicting infectious SARS-CoV-2 from diagnostic samples. Clinical Infectious Diseases. 2020 doi: 10.1093/cid/ciaa638. Epub ahead of print 22 May 2020. - DOI - PMC - PubMed
    1. CLSI . User protocol for evaluation of qualitative test performance; approved guideline—second edition: CLSI document EP12-A2. Wayne: Clinical and Laboratory Standards Institute; 2008.
    1. Diao B, Wen K, Chen J, Liu Y, Yuan Z, Han C, Chen J, Pan Y, Chen L, Dan Y, Wang J, Chen Y, Deng G, Zhou H, Wu Y. Diagnosis of acute respiratory syndrome coronavirus 2 infection by detection of nucleocapsid protein. 2020. https://www.medrxiv.org/content/10.1101/2020.03.07.20032524v2 https://www.medrxiv.org/content/10.1101/2020.03.07.20032524v2
    1. Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, Emperador D, Takwoingi Y, Cunningham J, Beese S, Dretzke J, Ferrante di Ruffano L, Harris IM, Price MJ, Taylor-Phillips S, Hooft L, Leeflang MM, Spijker R, Van den Bruel A, Cochrane COVID-19 Diagnostic Test Accuracy Group Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database of Systematic Reviews. 2020;8:CD013705. doi: 10.1002/14651858.CD013705. - DOI - PMC - PubMed
    1. Drosten C. Coronavirus update 54 (podcast), 1 Sept 2020. 2020. https://www.ndr.de/nachrichten/info/coronaskript222.pdf. [13 October 2020]. https://www.ndr.de/nachrichten/info/coronaskript222.pdf

LinkOut - more resources